Cortistatin as a potential multistep therapeutic agent for inflammatory disorders

Drug News and Perspectives

Volumn 19, Issue 7, 2006, Pages 393-399

  Gonzalez Rey, Elena ^a   Delgado, Mario ^a  

^a INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; CORTISTATIN; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ENDOTOXEMIA; ENTERITIS; HUMAN; IMMUNOLOGICAL TOLERANCE; INFLAMMATORY DISEASE; NONHUMAN; REVIEW; RHEUMATOID ARTHRITIS; SEPSIS; SEPTIC SHOCK; TH1 CELL;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS, RHEUMATOID; AUTOIMMUNE DISEASES; CLINICAL TRIALS; HUMANS; IMMUNOLOGIC FACTORS; INFLAMMATION; INFLAMMATORY BOWEL DISEASES; MACROPHAGES; NEUROPEPTIDES; SHOCK, SEPTIC; TH1 CELLS;

EID: 33750521135     PISSN: 02140934     EISSN: None     Source Type: Journal    
DOI: 10.1358/dnp.2006.19.7.1021490     Document Type: Review

References (35)

1. de Lecea, L., Criado, J.R., Prospero-Garcia, O. et al. A cortical neuropeptide with neuronal depressant and sleep-modulating properties. Nature 1996, 381: 242-5.
2. Spier, A.D. and de Lecea, L. Cortistatin: A member of the somatostatin neuropeptide family with distinct physiological functions. Brain Res Rev 2000, 33: 228-41.
3. Dalm, V.A. Expression of somatostatin, cortistatin, and somatostatin receptors in human monocytes, macrophages, and dendritic cells. Am J Physiol Endocrinol Metab 2003, 285: E344-53.
4. Dalm, V.A. Cortistatin rather than somatostatin as a potential endogenous ligand for somatostatin receptors in the human immune system. J Clin Endocrinol Metab 2003, 88: 270-6.
5. Gonzalez-Rey, E., Chorny, A., Robledo, G. and Delgado, M. Cortistatin, a new anti-inflammatory peptide with therapeutic effect on lethal endotoxemia. J Exp Med 2006, 103: 563-71.
6. Gonzalez-Rey, E., Varela, N. and Sheibiane, A.F. et al. Cortistatin, a new anti-inflammatory peptide with therapeutic action in inflammatory bowel disease. Proc Natl Acad Sci U S A 2006, 203: 4228-33.
7. Deghenghi, R., Papotti, M., Ghigo, E. and Muccioli, G. Cortistatin, but not somatostatin, binds to growth hormone secretagogue (GHS) receptors of human pituitary gland. J Endocrinol Invest 2001, 24: RC1-3.
8. Dixit, V.D., Schaffer, E.M., Pyle, R.S. et al. Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cells. J Clin Invest 2004, 114: 57-66.
9. Krantic, S. Peptides as regulators of the immune system: Emphasis on somatostatin. Peptides 2000, 21: 1941-64.
10. Danner, R.L., Elin, R.J. Hosseini, R.M., Wesley, R.A., Reilly, J.M. and Parillo, J.E. Endotoxemia in human septic shock. Chest 1991, 99: 169-75.
11. Netea, M.G., van der Meer, J.W., van Deuren, M. and Kullberg, B.J. Proinflammatory cytokines and sepsis syndrome: Not enough, or too much of a good thing? Trends Immunol 2003, 24: 254-8.
12. Bouch P.-Y. and Calandra, T. Pathogenesis of sepsis: New concepts and implications for future treatments. Br Med J 2003, 326: 262-6.
13. Sessler, C.N. and Shepherd, W. New concepts in sepsis. Curr Opin Crit Care 2002, 8: 465-72.
14. Tracey, K.J. and Cerami, A. Tumor necrosis factor, other cytokines and disease. Annu Rev Cell Biol 1993, 9: 317-43.
15. Liaw, Y.S., Yu, C.J., Wu, H.D. and Yang, P.C. Comparison of inflammatory cytokine concentration and physiologic parameters in septic shock. J Formos Med Assoc 1997, 96: 685-90.
16. Zeni, F., Freeman, B. and Natanson, C. Anti-inflammatory therapies to treat sepsis and septic shock: A reassessment. JAMA 1997, 25: 1095-100.
17. Starnes, H.F., Pearce, M.K., Tewari, A., Yim, J.H., Zou, J.C. and Abrams, J.S. Anti-IL-6 monoclonal antibodies protect against lethal E. coli infection and lethal tumor necrosis factor-alpha challenge in mice. J Immunol 1990, 145: 4185-91.
18. Fiocchi, C. Inflammatory bowel disease: Etiology and pathogenesis. Gastroenterology 1998, 11: 182-205.
19. Hanauer, S.B. and Present, D.H. The state of the art in the management of inflammatory bowel disease. Rev Gastroenterol Disord 2003, 3: 81-92.
20. Strober, W., Fuss, I.J. and Blumberg, R.S. The immunology of mucosal models of inflammation. Annu Rev Immunol 2002, 20: 495-549.
21. McCormack, G., Moriaty, D., O'Donoghue, D.P. et al. Tissue cytokine and chemokine expression in inflammatory bowel disease. Inflamm Res 2001, 50: 491-5.
22. Feldmann, M., Brennan, F.M. and Maini, R.N. Role of cytokines in rheumatoid arthritis. Ann Rev Immunol 1996, 14: 397-440.
23. Brand, D.D., Kang, A.H. and Rosloniec, E.F. Immunopathogenesis of collagen arthritis. Springer Semin Immunopathol 2003, 25: 3-18.
24. Anthony, D.D. and Haqqi, T.M. Collagen-induced arthritis in mice: An animal model to study the pathogenesis of rheumatoid arthritis. Clin Exp Rheumatol 1999, 17: 240-4.
25. Feldmann, M. and Maini, R.N. Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned? Annu Rev Immunol 2001, 19: 163-96.
26. Seki, N., Sudo, Y., Yoshioka, T. et al. Type II collagen-induced murine arthritis induction and perpetuation of arthritis require synergy between humoral and cell-mediated immunity. J Immunol 1988, 140: 1477-87.
27. + suppressor T cells: More questions than answer. Nat Rev Immunol 2002, 2: 816-22.
28. + T cell subset is related to Th1/Th2 balance and disease severity in rheumatoid arthritis. Arthritis Rheum 2000, 43: 617-27.
29. + depletion hastens the onset of severe disease in collagen-induced arthritis. Arthritis Rheum 2003, 48: 1452-60.
30. + T cells and the control of autoimmune disease. Curr Opin Immunol 2004, 16: 695-701.
31. Ramirez, J.L., Mouchantaf, R., Kumar, U. et al. Brain somatostatin receptors are upregulated in somatostatin-deficient mice. Mol Endocrinol 2002, 16: 1951-63.
32. Gonzalez-Rey, E., Chorny, A. and Delgado, M. Therapeutic action of ghrelin in an experimental model of colitis. Gastroenterology 2006, 13: 1707-20.
33. Criado, J.R., Li, H., Jiang, X. et al. Structural and compositional determinants of cortistatin activity. J Neurosci Res 1999, 56: 611-9.
34. Paran, D., Elkayam, O., Mayo, A. et al. A pilot study of a long acting somatostatin analogue for the treatment of refractory rheumatoid arthritis. Ann Rheum Dis 2001, 60: 888-91.
35. Takeba, Y., Suzuki, N, Takeno, M. et al. Modulation of synovial cell function by somatostatin in patients with rheumatoid arthritis. Arthritis Rheum 1997, 40: 2128-38.